Biotechnology

AIVITA Biomedical CEO Dr. Hans Keirstead to Deliver Keynote on AI in Healthcare at McKenna Institute Digital Innovation Summit

by

IRVINE, Calif., June 12, 2023 /PRNewswire/ — AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, today announced that chairman and CEO Dr. Hans Keirstead will deliver a keynote at the Digital Innovation Summit, taking place June 12-13 in St. Andrews, New Brunswick, Canada. Hosted by the University of New Brunswick’s McKenna … Read more

Successfully Concludes, Setting New Milestones in Allergy and Clinical Immunology

by

HAMBURG, Germany, June 12, 2023 /PRNewswire/ — The European Academy of Allergy and Clinical Immunology (EAACI) is pleased to announce the successful conclusion of its highly anticipated Annual Congress, held in Hamburg, Germany, from June 9 to 11. The congress brought together a distinguished gathering of leading experts, healthcare professionals, researchers, and industry representatives from … Read more

Translumina bolsters its German presence with acquisition of Lamed GmbH

by

NEW DELHI and MUNICH, June 12, 2023 /PRNewswire/ — Translumina, a global leader in interventional cardiovascular medical devices with manufacturing presence in Germany and India, today announced the acquisition of Munich-based Lamed GmbH. With this acquisition, Translumina has taken a step further towards its stated goal of providing a comprehensive cardiovascular portfolio at scale across … Read more

Blueprint Medicines Highlights Clinical Progress Across Precision Oncology Pipeline at 2023 ASCO Annual Meeting

by

— Breadth of pipeline featured in multiple early clinical data presentations, reflecting diversity of fundamental growth drivers across development programs — CAMBRIDGE, Mass., June 3, 2023 /PRNewswire/ — Blueprint Medicines Corporation (Nasdaq: BPMC) today announced clinical data for multiple programs across its precision therapy portfolio at the 2023 American Society of Clinical Oncology (ASCO) Annual … Read more

FDA Roundup: June 2, 2023

by

SILVER SPRING, Md., June 2, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA provided an update on medical device reports it received that are reportedly associated with the breakdown or suspected breakdown of the polyester-based polyurethane (PE-PUR) foam used … Read more

Le Dr Robin Edwards et le Dr David Ferry rejoignent l’équipe de direction clinique de Dragonfly pour aider à gérer son pipeline clinique en pleine croissance USA – Français USA – Deutsch USA – español USA – English USA – English

by

Six médicaments développés par Dragonfly sont actuellement en clinique. WALTHAM, Massachusetts, 2 juin 2023 /PRNewswire/ — Dragonfly Therapeutics, Inc., a annoncé aujourd’hui avoir élargi son équipe de direction clinique en y intégrant le Dr Robin Edwards, anciennement directeur mondial des sciences translationnelles chez Daiichi Sankyo et directeur des sciences translationnelles chez Bristol Myers Squibb, et … Read more

Aster Insights announces that The University of Kansas Cancer Center will join the Oncology Research Information Network (ORIEN)

by

Leading academic cancer research network led by Aster Insights accelerates oncology discovery and therapeutic development TAMPA, Fla. and KANSAS CITY, Kan., June 2, 2023 /PRNewswire/ — Aster Insights, the leading provider of technology-enabled data and analytics solutions for oncology discovery, today announced The University of Kansas Cancer Center will join its Oncology Research Information Exchange Network … Read more

Illumina’s Board of Directors elects two experienced Independent Directors to Board

by

Stephen P. MacMillan, Hologic CEO, named non-executive Chair of Illumina’s Board Scott B. Ullem, CFO of Edwards Lifesciences, also named to Board SAN DIEGO, June 2, 2023 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a series of governance changes consistent with the goal of enhancing long-term … Read more

Alkermes Appoints Caroline J. Loew, Ph.D., as Chief Executive Officer Designate of Mural Oncology plc

by

—  Dr. Loew to Assume New Leadership Role Upon Completion of the Planned Separation of Alkermes’ Oncology Business — —  Planned Separation Remains on Track to be Completed in Second Half of 2023 — DUBLIN, June 1, 2023 /PRNewswire/ — Alkermes plc (Nasdaq: ALKS) today announced that Caroline J. Loew, Ph.D., has been appointed as the … Read more

Brii Biosciences Announces First Subject Dosed in Phase 1 Clinical Trial of BRII-297, Long-Acting Injectable for the Treatment of Anxiety and Depressive Disorders USA – English APAC – English

by

BRII-297, a first-of-its-kind treatment option for anxiety and depressive disorders, has the potential to enable greater therapeutic adherence and convenience for patients DURHAM, N.C. and BEIJING, May 31, 2023 /PRNewswire/ — Brii Biosciences Limited (“Brii Bio” or the “Company”, stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across diseases with … Read more